BioLargo, Inc. is an environmental technology innovator creating solutions for air and water quality, energy storage, medical antimicrobial devices, and engineering services.

# Company Summary: BioLargo, Inc.

## Overview
BioLargo, Inc. is an innovator and solution provider focusing on creating disruptive cleantech technologies to address significant environmental challenges. The company invents, develops, and commercializes solutions across air quality, water treatment, environmental engineering, battery energy storage, and medical antimicrobial devices.

## Business Segments
- **Odor and VOC control products:** Developed for both consumer and industrial use, including private label brands (e.g., Pooph pet deodorizer and CupriDyne Clean Industrial Odor Eliminator).
- **Water treatment solutions:** Technologies such as PFAS removal (Aqueous Electrostatic Concentrator - AEC), water recycling (AROS), and disinfection (AOS), sold through BioLargo Equipment Solutions & Technologies.
- **Battery energy storage systems:** Using proprietary liquid sodium chemistry, under development by BioLargo Energy Technologies, Inc.
- **Medical products:** Including FDA-cleared wound irrigation solutions (Bioclynse) developed by Clyra Medical Technologies.
- **Engineering services:** Provided by BioLargo Engineering, Science & Technologies, supporting internal projects and external clients.
- **Research & development:** Mainly conducted at BioLargo Canada in Edmonton, Alberta.

## Employees
- As of March 28, 2025, **44 employees** (including professional engineers, PhDs, sales, support, and administrative staff).

## Customers and Revenue
- **Revenue (2024):** $17.779 million, representing a **45% increase** from 2023.
- **Product revenue:** $16.762 million.
- **Service revenue:** $1.017 million.
- The company's largest private label product, Pooph, accounts for **77% of total revenue** for 2024.
- **Major customer dependency:** Over 77% of revenue was derived from Pooph sales, which are marketed by Pooph Inc., a third-party company. Revenue from Pooph in 2024 was approximately $13.3 million.
  
## Revenue Breakdown
- **Odor control (ONM Environmental):** $15.597 million (36% increase from 2023). Primarily from private-label Pooph sales and odor control services.
- **Engineering division (BLEST):** $2.182 million (183% increase from 2023). Includes third-party water treatment system sales and internal projects.
- **Medical (Clyra Medical):** Not yet in commercial sales; operating loss of $3.324 million in 2024.
- **Battery tech (BETI):** Operating loss of $642,000.
- **Water equipment (BEST):** Operating loss of $273,000.

## Income & Loss
- **Net loss (2024):** $4.347 million, compared to $4.648 million in 2023.
- Losses are primarily driven by R&D expenses and operating costs; net loss per share is $0.01.
- **Operating income (on odor control segment):** $5.92 million in 2024, up from $4.33 million in 2023, mainly from Pooph sales.

## Additional Details
- **Market Value:** The company's market cap was approximately $61.386 million as of the last reporting date.
- **Shares Outstanding:** 301,303,131 as of March 28, 2025.
- **Ownership & Stock Trading:** Quoted on OTCQX under ticker "BLGO"; about 530 registered shareholders and 5,300 beneficial owners.
- **Key Focus:** Developing innovative clean tech solutions to environmental problems (PFAS, micropollutants, VOCs, odors, infection control, and energy storage). The company emphasizes partnerships and licensing to expand market reach.

This summary reflects the company's operations, financials, and organizational structure based explicitly on provided data, with no hypotheticals included.

BioLargo, Inc. is a technology and solution provider focused on developing innovative cleantech solutions to address global challenges in air quality, water treatment, and health-related technologies.

# BioLargo, Inc. Overview

## Company Description
BioLargo, Inc. is a technology and solution provider focused on developing innovative cleantech solutions to address global challenges related to air quality, water treatment, environmental engineering, battery energy storage, and advanced antimicrobial medical technologies. The company operates through several subsidiaries and aims to commercialize disruptive technologies that provide affordable and effective solutions for environmental and health-related issues.

### Subsidiaries and Technologies
- **ONM Environmental, Inc.**: Specializes in odor and volatile organic compound (VOC) control products.
  - **Key Product**: CupriDyne Clean, used in both industrial and consumer applications.
  - **Revenue Contribution**: Revenue from the Pooph branded pet odor control product accounts for approximately 82% of the company's total revenue.
  
- **BioLargo Equipment Solutions & Technologies, Inc. (BEST)**: Focuses on innovative water treatment solutions.
  - **Key Products**: 
    - **Aqueous Electrostatic Concentrator (AEC)**: Removes PFAS contaminants from water at lower costs and waste production.
    - **Aqueous Reuse Optimization System (AROS)**: Minimizes industrial wastewater discharges.
    - **Advanced Oxidation System (AOS)**: Targets micropollutants and pathogens in water.
  
- **BioLargo Energy Technologies, Inc. (BETI)**: Developing proprietary liquid sodium battery technology aimed at addressing the growing energy storage market.
  - **Ownership**: BioLargo owns 96% of BETI.
  
- **Clyra Medical Technologies, Inc.**: Focuses on medical products.
  - **Key Product**: Bioclynse, a surgical wound irrigation solution with proven efficacy.

- **BioLargo Engineering, Science & Technologies, LLC (BLEST)**: Provides environmental engineering services and supports the development of internal projects.

## Financial Performance
- **Revenue**: For the year ended December 31, 2023, the company recorded approximately **$1.89 million** in revenue.
- **Net Loss**: The net loss for 2023 was approximately **$4.65 million**, following a loss of **$5.13 million** in the previous year (2022).
- **Working Capital**: As of December 31, 2023, the company had working capital of approximately **$3.65 million** and cash and cash equivalents of **$3.54 million**.

## Workforce
- **Employees**: As of March 29, 2024, BioLargo has **33 employees**, with 31 of them being full-time. The workforce includes professional engineers, scientists, and administrative personnel.
  
## Customer Base
- **Customer Concentration**: A significant portion of revenues is derived from one customer selling private-label pet odor control products. This customer accounted for **82%** of total revenue in 2023. 

## Market Focus
BioLargo targets several areas of focus, including:
- **Environmental Challenges**: Addressing issues such as PFAS contamination, water pollution, air pollution, and infection control.
- **Innovative Technologies**: Focus on developing and commercializing cutting-edge technologies with a strong emphasis on sustainability and public health.

Through its various subsidiaries and innovative technologies, BioLargo aims to provide solutions that meet pressing environmental challenges and improve the quality of life worldwide.

BIOLARGO, INC.

10-K / March 31, 2025

10-K / April 1, 2024

10-K / March 31, 2025

Company Summary: BioLargo, Inc.

Overview

Business Segments

Employees

Customers and Revenue

Revenue Breakdown

Income & Loss

Additional Details